Merus NV MRUS
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 75.85M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 113.03
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 260
- Website
- https://www.merus.nl
Valuation
|
Metric
|
MRUS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 8.81 |
Price/Sales | 113.03 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MRUS
|
|---|---|
Quick Ratio | 7.59 |
Current Ratio | 7.97 |
Interest Coverage | — |
Quick Ratio
MRUS
Profitability
|
Metric
|
MRUS
|
|---|---|
Return on Assets (Normalized) | −35.48% |
Return on Equity (Normalized) | −42.23% |
Return on Invested Capital (Normalized) | −44.84% |
Return on Assets
MRUS
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|n>>$SN^ | LOCK|F>$T | $127B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|N??P@b | LOCK|>dW& | $76B | |||
| Moderna Inc
MRNA
| LOCK|vDy&><$ | LOCK|?# | $75B | |||
| argenx SE ADR
ARGX
| LOCK|g>>F>@ | LOCK|S#D | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|!#Gvm?& | LOCK|Bt | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|RkKHw%P | LOCK|#xTg% | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|>#>&QTz | LOCK|V<fl | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|#<y>p@@ | LOCK|>R | $24B | |||
| Incyte Corp
INCY
| LOCK|w?vl#z$ | LOCK|L%< | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|<C@^mv | LOCK|@F | $15B |
United States